A tumor found with most of its mass located in the heart including the pericardium is identified as PCL. By definition, those patients with small secondary lesions of the same disease in other parts of the body are included in the PCL group. 2 Usually, PCL occurs in the right atrium and right ventricle of the heart. Its clinical manifestations are found when the presence of heart failure, pericardial effusion, cardiomegaly, and arrhythmia are noted. The prognosis of PCL is typically quite poor because of delayed diagnosis. The diagnostic instruments and methods for PCL include chest X-ray, echocardiography, computed tomography (CT) scan, magnetic resonance imaging (MRI), and radioisotope scan. The final confirmative diagnosis is made from the cytology of pericardial effusive and/or tumor tissue biopsy. The diagnosis depends on the correct specimen having been obtained, including the aspiration of pericardial effusive fluid and biopsy through cardiac catheterization or surgery. The diagnostic procedures should be done rapidly and accurately. Chemotherapy is quite effective for PCL. Usually, the tumor cannot be resected with surgery. The prognosis for PCL is generally poor. 2 
Case Report
We report on a 58-year-old man who was transferred from another hospital in June 2002 because of chronic cough for 4 months and chest pain with shortness of breath for 1 week. On admission, there were no remarkable physical findings. Hemogram revealed hemoglobin (Hb) 13.19 g/dL, white blood cells (WBC) 10,100/mm 3 , platelets 280,000/mm 3 , neutrophils 66.5%, lymphocytes 24.9%, and monocytes 6.0%. Blood biochemistry examinations showed albumin 3.3 g/dL, globulin 3.8 g/dL, and lactic acid dehydrogenase 2,151 MU/L. Liver and renal functions, and blood sugar were all within normal limits. Tests for HBsAg, anti-HCV, and anti-HIV were negative. Chest X-ray showed an enlarged heart. Electrocardiogram showed a low voltage wave indicative of 2nd degree A-V block. Echocardiography revealed a tumor from the free wall of the right atrium entering the right ventricle ( Figure  1 ). The tumor was about 8 × 5 cm in size. Besides a thickened pericardium, there was a large amount of fluid accumulated inside. On the day of admission, pericardiotomy with drainage was performed. A total of 300 mL of straw-colored fluid was drained. The pathologic examination of the fluid revealed many large lymphoid cells, which were proven B cells, with positive immunocytochemical stains for CD20. Involvement of lymphoma in the pericardium was suspected. Biopsy of the pericardium also revealed the presence of large lymphoid cells. On the 10th day after admission, a biopsy of the heart tumor was performed using catheterization. The pathologic examination showed a picture of large B-cell lymphoma, diffuse type ( Figure  2 ). Immunocytochemical stains of the sections of tumor exhibited large lymphoid cells positive for leukocyte common antigen and CD20, and negative for chromogranin-A, S-100, and T cells. A series of wholebody examinations for the staging of cancer were performed, including CT scan of the heart and whole abdomen, MRI of the heart, gastrointestinal series, and whole-body tumor Gallium scan. A tumor 8 × 5 cm in size with variable lobes located in the atrium and ventricle of the right side was noted ( Figure 3 ). There were no tumors found in other parts of the body. The patient was initially treated with chemotherapy, i.e. 2 courses of COP (cyclophosphamide + vincristine + prednisone). The tumor shrank to 2.7 cm in size. This treatment was then followed by 4 courses of COP and 2 courses of CHOPBE (COP + doxorubicin + bleomycin + etoposide), after which the intracardiac tumor disappeared (Figure 4) . However, the pericardial tumor was persistent. After a pause following chemotherapy, a dose of 4,160 cGy radiotherapy was applied. The patient developed pneumonia, pulmonary edema, and sepsis. He died 12 months after the diagnosis of PCL was established.
Discussion
This case featured lymphoma with the biggest mass found inside the heart and was compatible with the diagnostic basis for PCL. The tumor was found in the patient's right atrium and right ventricle. There were no tumors found in other parts of his body. In a previous similar reported case (Table 1) , 4 also from this hospital, there was perforation of the ileum with peritonitis about 1.5 months before the diagnosis of PCL was established. Both cases were male, one aged 58 years and one 68 years, which is compatible with the observation that most patients are aged males. However, the disease has also recently been found in a few cases of children. 15 The location of PCL reflects its pathophysiology and clinical symptoms and signs. A tumor in the heart may develop embolism, A-V block, thrombosis, and even strokes. Disturbance of hemodynamics may result. 16 Most frequently, the tumor is found to be located partly in the right atrium. It may disturb the tricuspid and aortic valves, cause heart failure, pulmonary hypertension, and aortic valvular obstruction. In this reported case, the tumor was located mostly in the right atrium. It was found, by echocardiography, CT scan, and MRI of the heart, that the tumor had extended to the right ventricle. However, embolism, thrombosis, and heart failure were not evident. Heart failure and arrhythmia may be caused by tumor extension to the myocardium. In the 68-year-old patient with complete A-V block mentioned earlier, the condition was so serious that a cardiac pacemaker had to be implanted urgently. 4 In our case, 2nd-degree A-V block developed. After effective chemotherapy, the cardiac arrhythmias of both these cases returned to normal. If the disease involves the pericardium, effusion or hemorrhage may develop and be followed by A-V block, constrictive pericarditis, or symptoms and signs of great vessel obstruction. In this case, there was a large amount of accumulated pericardial effusive fluid, which caused shortness of breath and chest oppression. In the effusive fluid, cancer cells indicative of PCL were identified. It was found that the disease involved the patient's pericardium, resulting in common clinical manifestations such as palpitation, shortness of breath, chest oppression, and cough related to heart failure, pleural irritation, A-V block, arrhythmia, and pleural effusion. However, thromboembolism, myocardial infarction, rupture of the heart, coma, or sudden death were not observed in this case. Intestinal perforation before the diagnosis of PCL has been reported. 4 Tumor-associated cardiac wall rupture has been described in PCL. 15 The 3 most commonly encountered clinical manifestations of PCL are pericardial effusion, heart failure, and A-V block (Table 1) .
PCL is a variant of non-Hodgkin's lymphoma (NHL). Its prevalence has increased in the USA, which is probably related to AIDS or drug abuse in which acquired immune deficiency is observed. Fifteen to 25% of NHLs in adults are extranodal lymphomas, but in AIDS patients they constitute about 90%. 16 Extranodal lymphoma is usually found in the stomach and intestines, nasopharynx, skin, bones, thyroid gland, breasts, lungs, testes, and brain. This reported case had no AIDS, proven by a negative anti-HIV test. PCL is rare clinically, although reports on the frequency of secondary lymphoma spreading to the heart state a range of 16-28%. Echocardiography is a more convenient diagnostic method that can detect pericardial effusion and the presence of tumors in the heart. It may be followed by CT and MRI scans to detect the extent of involvement and the size of the tumor. 19 In this case, we found that echocardiography was more convenient. The diagnosis of PCL in this case was further confirmed through cardiac catheterization and tumor biopsy during hospitalization. Initially, lymphoid cells were also found in the patient's pericardial effusive fluids. It has been reported that biopsy through cardiac catheterization and chest surgery can confirm the diagnosis of PCL. 18, 20 As in this case, the diagnosis of PCL was made by tissue biopsy through exploratory sternotomy and cardiac catheterization.
More than 80% of PCLs are noted as diffuse B-cell lymphomas, mostly with a large cell type (Table 1) , but other cell types also present, e.g. T-cell lymphoma. 21 In recent years, PCL related to immune deficiency has been found as small noncleaved or immunoblastic lymphoma pathologically. 15 Immunoblastic lymphoma is more invasive. In this case, the cells were mediumto-large sized cells.
The therapeutic effect in PCL is usually not promising. 18, 19, [22] [23] [24] It is difficult to resect by surgery. Because the tumors are mostly large B-cell lymphomas, they are therefore sensitive to chemotherapy. The main chemotherapy regimens are COP and CHOP (cyclophosphamide, doxorubicin + vincristine + prednisone) (Table 1) . 4, 22 Patients treated with CHOP may survive for up to 18 months. 4, 24 It has been reported that patients treated with the BACOP protocol (bleomycin + doxorubicin + cyclophosphamide + vincristine + prednisone) might survive for up to 49 months. 23 With surgical resection, the patients might survive for more than 18 months, 18, 20 and with radiotherapy for up to 15 months. Heart transplantation 22 or combination therapies have also been tried. 24 In recent years, stem-cell transplantation has been used in combination with other chemotherapies in association with Rutuximab, to achieve complete remission in some cases. 12 This patient received chemotherapy associated with radiotherapy, and survived for only 1 year. The causes of death in this case of PCL may be related to refractory control of the disease itself 2, 13, 14 and/or therapeutic complications, such as neutropenia with sepsis, cardiotoxicity-related fatal arrhythmia, or rupture of the heart 12 ( Table 1) . It is still possible to treat this rare disease with high doses of chemotherapy in the status of long-term remission. 4, 7, 12, 15 To avoid the marrow suppression complications of intensive therapy, stem-cell transplantation may be considered, especially in cases with clinically aggressive PCL. We think that therapeutic efficacy was less than expected in this patient because the diagnosis was made too late and the tumor was large and had extended into the pericardium, myocardium, and endocardium.
